Subscribe to the BioNews newsletter for free

Advanced Search

Search for

Like the Progress Educational Trust on Facebook

Suzanne Elvidge

Suzanne Elvidge was previously a Volunteer Writer at BioNews, and is a freelance science and health writer and editor with more than 20 years of experience. She studied biochemistry and pharmacology, and went on to obtain an MSc at the Open University which included a module in communicating science. She has written for publications including European Life Science, the Journal of Life Sciences (now the Burrill Report), In Vivo, Life Science Leader, Nature Biotechnology, PR Week and Start-Up. She specialises in writing on pharmaceuticals, biotechnology, healthcare, science, lifestyle and green living, but can write on any topic given enough tea and chocolate biscuits.


BioNews Review articles written by Suzanne Elvidge:

Book Review: Ethical Challenges in Genomics Research - A Guide to Understanding Ethics in Context

03 September 2012 - by Suzanne Elvidge

While it's not designed to be something that is read from cover to cover, this textbook is clearly and well written, readable and accessible, with regular call-out boxes providing examples and case studies... [Read More]

TV Review: Horizon - Are You Good or Evil?

19 September 2011 - by Suzanne Elvidge

Good and evil have always been moral perspectives, but this edition of BBC One's science programme Horizon has pulled them firmly into the scientific realm, with an analysis of the science behind good and evil.... [Read More]

BioNews News articles written by Suzanne Elvidge:


Five million births from IVF: study published

21 October 2013 - by Suzanne Elvidge

Since the birth of Louise Brown in July 1978, five million babies have been born with the help of IVF and other assisted reproductive technologies... [Read More]

Cancer treatment should be based on gene 'fingerprints', says study

07 May 2013 - by Suzanne Elvidge

Genetic analysis of tumours provides the key to treating them effectively, according to two studies carried out by The Cancer Genome Atlas (TCGA).... [Read More]

Rare form of autism treated with dietary supplement

10 September 2012 - by Suzanne Elvidge

A rare form of autism, caused by a mutation that alters amino acid metabolism, could potentially be treated with a nutritional supplement, according to an international team of researchers... [Read More]

Five million IVF babies born to date, study says

02 July 2012 - by Suzanne Elvidge

A study estimates that five million people worldwide have been born thanks to assisted reproductive technologies... [Read More]

Personalised medicine details diabetes development for one scientist

19 March 2012 - by Suzanne Elvidge

Personalised medicine doesn't get much more personal than this. For more than two years, researchers at the Stanford University School of Medicine have been focusing on one person's genetic profile – that of their colleague and fellow geneticist, Dr Michael Snyder... [Read More]

Gene survey: Do you want to know your future diseases?

06 February 2012 - by Suzanne Elvidge

The idea of whole genome sequencing is becoming ever more popular, but it could mean you end up with more information than you bargained for; from your resistance to certain drugs to your risk of developing a range of diseases. But would you want to know? The Wellcome Trust Sanger Institute ethics team has launched a survey to find out what people really do (and don't) want to know about their genomes... [Read More]

First chimeric monkeys born in US

09 January 2012 - by Suzanne Elvidge

Three chimeric rhesus monkeys born in the USA have been described as the world's first primate chimeras... [Read More]

Mouse study offers hope for treating leading genetic cause of infant death

28 November 2011 - by Suzanne Elvidge

Researchers have made a step forward in the treatment of spinal muscular atrophy, a serious genetic disorder, by using a stretch of RNA to trigger mice into producing a back-up version of a missing protein... [Read More]

Aspirin cuts hereditary bowel cancer risk by 60 percent

31 October 2011 - by Suzanne Elvidge

Taking a daily aspirin has been recommended for people with a high risk of an inherited form of bowel cancer. Results published in The Lancet suggested the risk for those with Lynch syndrome could be cut by 63 percent... [Read More]

Mapping the epigenome: Europe leads the way

03 October 2011 - by Suzanne Elvidge

The European Commission (EC) is investing €30 million in BLUEPRINT, a project to map the human epigenome - the sum total of the non-coding, but inherited, modifications to DNA... [Read More]




Published by the Progress Educational Trust
Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation